NMDA Receptors as Potential Therapeutic Targets in Diabetic Nephropathy: Increased Renal NMDA Receptor Subunit Expression in Akita Mice and Reduced Nephropathy Following Sustained Treatment With Memantine or MK-801
N-methyl-d-aspartate (NMDA) receptors are expressed throughout the kidney, and the abundance of these receptors and some of their endogenous agonists are increased in diabetes. Moreover, sustained activation of podocyte NMDA receptors induces Ca2+ influx, oxidative stress, loss of slit diaphragm pro...
Main Authors: | Roshanravan, Hila, Kim, Eun Young, Dryer, Stuart E. |
---|---|
Format: | Online |
Language: | English |
Published: |
American Diabetes Association
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033270/ |
Similar Items
-
Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg2+ and memantine under conditions of agonist exposure
by: McKay, Sean, et al.
Published: (2013) -
Cell type-specific pharmacology of NMDA receptors using masked MK801
by: Yang, Yunlei, et al.
Published: (2015) -
Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801
by: Bygrave, A M, et al.
Published: (2016) -
Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
by: Takahashi, Hiroto, et al.
Published: (2015) -
Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
by: Takahashi, Hiroto, et al.
Published: (2016)